Hipan-DSR Tablet is a combination medication containing Domperidone 30 mg and Pantoprazole 40 mg, formulated to manage gastrointestinal disorders characterized by acid reflux, heartburn, and delayed gastric emptying. Domperidone, a peripheral dopamine D2 receptor antagonist, enhances gastrointestinal motility by increasing the movement of the stomach and intestines, thereby facilitating gastric emptying and reducing symptoms such as nausea and vomiting. Pantoprazole, a proton pump inhibitor, suppresses gastric acid secretion by inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells, providing effective relief from acid-related conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, and Zollinger-Ellison syndrome. The synergistic action of these two agents offers comprehensive management of upper gastrointestinal symptoms by addressing both motility and acid secretion abnormalities. Hipan-DSR is indicated for patients requiring acid suppression alongside prokinetic therapy, particularly those with coexisting reflux symptoms and delayed gastric emptying. It should be used under medical supervision, considering contraindications such as hypersensitivity to components, underlying cardiac conditions, or concurrent use of medications that may prolong QT interval. Adherence to prescribed dosage and monitoring for adverse effects are essential to ensure therapeutic efficacy and safety.